Study links hormone to reduced risk of type 2 diabetes

10/25/2011 | Endocrine Today

Each increase of one standard deviation in log-transformed N-terminal fragment of pro-B-type natriuretic peptide, a hormone that maintains cardiovascular function, reduced type 2 diabetes risk by 21%, according to an analysis of a case-cohort study in PLoS Medicine. However, more studies are needed to back the findings, researchers said.

View Full Article in:

Endocrine Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO